Novel Drug for Treatment of Type 2 Diabetes

In the United States, 1 in 10 individuals has diabetes, which affects how the body processes food into energy. One potential therapy is a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1) that aims to control blood sugar. Injected under the skin, GLP-1 and GIP receptors cause the pancreas to release insulin and block the hormone glucagon, limiting blood sugar spikes after a meal. Additionally, it slows digestion, resulting in individuals remaining full longer and eating less. Thus far, late phase III clinical trials reveal that the treatment significantly reduces hemoglobin A1C in type 2 diabetes and supports weight loss, making it potentially the most effective therapy for diabetes and obesity yet developed.

▶Subscribe to learn more about Cleveland Clinic:

#ClevelandClinic #MedicalInnovations

[ketroschniba]

can this also be used for LADA patients who still produce insuline?

[surajsonkar]

How to titment daibities medicine in world pls help muman

[sarahreuben]

Your endless compassion towards humanity Dr maco has broader my heart, I never wanted to have a surgery and prove all the doctors here that they were wrong and I really didn't know what else to do, than believe in your medicine, thanks so much for curing my type two diabetes. You are a life saver Dr maco

[surajsonkar]

How to human being am waiting pls pls help to human